Si-Bone Stock Surges Nearly 20% on Strong Q1 Results
Si-Bone (SIBN) stock surged nearly 20% after reporting better-than-expected first-quarter results and raising full-year guidance. The medical device company reported revenue of $52.6 million, up over 11% year-over-year, with a narrowed net loss under GAAP to $4.3 million.
Tickers: $SIBN